Bibliography

Export 85 results:
Filters: Keyword is *Terminal Care  [Clear All Filters]
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
M
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
Morrison-Koechl J., Heckman G., Banerjee A., Keller H..  2024.  Factors associated with dietitian referrals to support long-term care residents advancing towards the end of life. J Hum Nutr Diet. 37(3):673-684.
K
Koechl J., Banerjee A., Heckman G., Keller H..  2024.  Factors Associated With the Initiation of Comfort-Focused Nutrition Care Orders for Long-Term Care Residents at End of Life. Int J Older People Nurs. 19(5):e12634.
H
Hsu AT, Manuel DG, Spruin S, Bennett C, Taljaard M, Beach S, Sequeira Y, Talarico R, Chalifoux M, Kobewka D et al..  2021.  Predicting death in home care users: derivation and validation of the Risk Evaluation for Support: Predictions for Elder-Life in the Community Tool (RESPECT). CMAJ. 193(26):E997-E1005.
M
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
H
Hsu AT, Manuel DG, Spruin S, Bennett C, Taljaard M, Beach S, Sequeira Y, Talarico R, Chalifoux M, Kobewka D et al..  2021.  Predicting death in home care users: derivation and validation of the Risk Evaluation for Support: Predictions for Elder-Life in the Community Tool (RESPECT). CMAJ. 193(26):E997-E1005.
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
S
Steindal SA, Bredal ISchou, Sørbye LWergeland, Lerdal A.  2011.  Pain control at the end of life: a comparative study of hospitalized cancer and noncancer patients. Scandinavian Journal of Caring Sciences. 25(4):771-9.
Steindal S.A, Sorbye L.W, Bredal I.S, Lerdal A..  2012.  Agreement in documentation of symptoms, clinical signs, and treatment at the end of life: a comparison of data retrieved from nurse interviews and electronic patient records using the Resident Assessment Instrument for Palliative Care. Journal of Clinical Nursing. 21(9-10):1416-24.
M
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
H
Hsu AT, Manuel DG, Spruin S, Bennett C, Taljaard M, Beach S, Sequeira Y, Talarico R, Chalifoux M, Kobewka D et al..  2021.  Predicting death in home care users: derivation and validation of the Risk Evaluation for Support: Predictions for Elder-Life in the Community Tool (RESPECT). CMAJ. 193(26):E997-E1005.
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
H
Hsu AT, Manuel DG, Spruin S, Bennett C, Taljaard M, Beach S, Sequeira Y, Talarico R, Chalifoux M, Kobewka D et al..  2021.  Predicting death in home care users: derivation and validation of the Risk Evaluation for Support: Predictions for Elder-Life in the Community Tool (RESPECT). CMAJ. 193(26):E997-E1005.
E
Estabrooks C.A, Hoben M., Poss J.W, Chamberlain S.A, Thompson G.N, Silvius J.L, Norton P.G.  2015.  Dying in a Nursing Home: Treatable Symptom Burden and its Link to Modifiable Features of Work Context. Journal of the American Medical Directors Association. 16(6):515-520.
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
H
Hsu AT, Manuel DG, Spruin S, Bennett C, Taljaard M, Beach S, Sequeira Y, Talarico R, Chalifoux M, Kobewka D et al..  2021.  Predicting death in home care users: derivation and validation of the Risk Evaluation for Support: Predictions for Elder-Life in the Community Tool (RESPECT). CMAJ. 193(26):E997-E1005.
G
Gessert C.E, Curry N.M, Robinson A..  2001.  Ethnicity and end-of-life care: the use of feeding tubes. Ethn Dis. 11(1):97-106.
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
E
Estabrooks C.A, Hoben M., Poss J.W, Chamberlain S.A, Thompson G.N, Silvius J.L, Norton P.G.  2015.  Dying in a Nursing Home: Treatable Symptom Burden and its Link to Modifiable Features of Work Context. Journal of the American Medical Directors Association. 16(6):515-520.
F
Fernandes S., Guthrie D.M.  2015.  A comparison between end-of-life home care clients with cancer and heart failure in Ontario. Home Health Care Serv Q. 34(1):14-29.
M
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.
K
Kruizinga J, Fisher K, Guthrie D, Northwood M, Kaasalainen S.  2024.  Comparing quality indicator rates for home care clients receiving palliative and end-of-life care before and during the Covid-19 pandemic. BMC palliative care. 23(1):11.
F
Fremont D., Roberts R.L, Webber C., Clarke A.E, Milani C., Isenberg S.R, Bush S.H, Kobewka D., Turcotte L., Howard M. et al..  2024.  Changes in End-of-Life Symptom Management Prescribing among Long-Term Care Residents during COVID-19. J Am Med Dir Assoc. 25(6):104955.
M
Matlow J.N, Bronskill S.E, Gruneir A., Bell C.M, Stall N.M, Herrmann N., Seitz D.P, Gill S.S, Austin P.C, Fischer H.D et al..  2017.  Use of Medications of Questionable Benefit at the End of Life in Nursing Home Residents with Advanced Dementia. Journal of the American Geriatrics Society. 65(7):1535-1542.